Genoskin is a Contract Research Organisation (CRO) developing ex vivo human skin platforms capable of testing injected drugs and implanted medical devices as a scalable alternative to animal testing.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €8.7 M | Sep, 2025 | seed |
Industries
Frequently Asked Questions
What industries does Genoskin operate in?
Genoskin operates in the following industries: biotechnology, pharmaceutical, cosmetics.
How much total funding has Genoskin raised?
Genoskin has raised a total of $8,700,000.
Who are the investors in Genoskin?
The investors in Genoskin are: OCCTE (FPCI Occidev Impacts), Captech Santé, GSO Innovation, CA Toulouse 31 Initiatives, Bpifrance, BNP Paribas, Caisse d’Epargne Midi-Pyrénées, Crédit Agricole.